Screening for Lung Cancer: Recent Experience in the United States

  • Robert S. Fontana
Part of the Cancer Treatment and Research book series (CTAR, volume 28)

Abstract

From November, 1971, through December, 1984, the United States National Cancer Institute (NCI) sponsored three large-scale, long-term, randomized controlled trials of screening for early lung cancer. The trials were conducted at the Johns Hopkins Medical Institutions, the Memorial Sloan-Kettering Cancer Center, and the Mayo Clinic [1–3].

Keywords

Adenocarcinoma Beach Smoke Tated Nash 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    National Cancer Institute Cooperative Early Lung Cancer Group. Manual of Procedures, second edition. Washington DC: Government Printing Office, 1979 (NIH Publication No 79, 1972).Google Scholar
  2. 2.
    Fontana RS, Sanderson DR, Taylor WF et al.: Early lung cancer detection: results of the initial (prevalence) radiologic screening in the Mayo Clinic study. Am Rev Respir Dis 130:561–565, 1984.PubMedGoogle Scholar
  3. 3.
    Study groups find little support for lung screening. Diagnostic Imaging 16–17 (Jan) 1985.Google Scholar
  4. 4.
    US Department of Health, Education, and Welfare. Smoking and health. Report of the advisory committee to the Surgeon General of the Public Health Service, 1964 (Public Health Service Publication No 1103).Google Scholar
  5. 5.
    1973 Cancer facts and figures. American Cancer Society, New York, 1972.Google Scholar
  6. 6a.
    Doll R, Hill AB: Mortality in relation to smoking: Ten years’ observations of British doctors. Br Med J 1:1399–1410, 1964.PubMedCrossRefGoogle Scholar
  7. 6b.
    Doll R, Hill AB: Mortality in relation to smoking: Ten years’ observations of British doctors. Br Med J 1:1460–1467, 1964.PubMedCrossRefGoogle Scholar
  8. 7.
    US Department of Health and Human Services. The health consequences of smoking. Cancer. A report of the Surgeon General. Washington, DC. Government Printing Office, 1982 (DHHS, PHS 82–50179).Google Scholar
  9. 8.
    Jett JR, Cortese DA, Fontana RS: Lung cancer: Current concepts and prospects. CA-A Cancer J for Clinicians 33:74–86, 1983.CrossRefGoogle Scholar
  10. 9.
    Williams DE, Pairolero PC, Davis CS et al.: Survival of patients surgically treated for stage I lung cancer. J Thorac Cardio vase Surg 82:70–76, 1981.Google Scholar
  11. 10.
    Ries LG, Pollack ES, Young JL: Cancer patient survival: Surveillance, epidemiology, and end results program, 1973–1979. JNCI 70:693–707, 1983.PubMedGoogle Scholar
  12. 11.
    World Health Organization: The World Health Organization histological typing of lung tumours. Second Edition. Am J Clin Pathol 77:123–136, 1982.Google Scholar
  13. 12.
    Clagett OT, Allen TH, Payne WS, Woolner LB: The surgical treatment of pulmonary neoplasms: A 10-year experience. J Thorac Cardio vase Surg 48:391–399, 1964.Google Scholar
  14. 13.
    American Joint Committee on Cancer: Manual for Staging of Cancer. Second Edition. Edited by OH Beahrs, MH Myers. Philadelphia, JB Lippincott Co., 1983, pp 99–105.Google Scholar
  15. 14.
    Davies DF: A review of detection methods for the early diagnosis of lung cancer. J Chronic Dis 19:819–845, 1966.PubMedCrossRefGoogle Scholar
  16. 15.
    Woolner LB, David E, Fontana RS et al.: In situ and early invasive bronchogenic carcinoma: Report of 28 cases with postoperative survival data. J Thorac Cardiovasc Surg 60:275–290, 1970.PubMedGoogle Scholar
  17. 16.
    Jackman RJ, Good CA, Clagett OT, Woolner LB: Survival rates in peripheral bronchogenic carcinomas up to four centimeters in diameter presenting as solitary pulmonary nodules. J Thorac Cardiovasc Surg 57:1–8, 1969.PubMedGoogle Scholar
  18. 17.
    Brett GZ: Earlier diagnosis and survival in lung cancer study. Br Med J 4:260–262, 1969.PubMedCrossRefGoogle Scholar
  19. 18.
    Brett GZ: The value of lung cancer detection by six-monthly chest radiographs. Thorax 23:414–420, 1968.PubMedCrossRefGoogle Scholar
  20. 19.
    Nash FA, Morgan JM, Tomkins JG: South London cancer study. Br Med J 2:715–721, 1968.PubMedCrossRefGoogle Scholar
  21. 20.
    Weiss W, Boucot KR, Seidman H: The Philadelphia pulmonary neoplasm research project. Clin Chest Med 3:243–256, 1982.PubMedGoogle Scholar
  22. 21.
    Lillienfeld A, Archer PG, Burnett LH et al.: An evaluation of radiologic and cytologic screening for early detection of lung cancer: A cooperative pilot study of the American Cancer Society and the Veterans Administration. Cancer Res 26:2083–2121, 1966.Google Scholar
  23. 22.
    Grzybowski S, Coy P: Early diagnosis of carcinoma of the lung. Cancer 25:113–120, 1970.PubMedGoogle Scholar
  24. 23.
    Brogdon BG, Kelsey CA, Moseley RD Jr: Factors affecting perception of pulmonary lesions. Radiol Clin North Am 21:633–654, 1983.PubMedGoogle Scholar
  25. 24.
    Russell WO, Neidhart HW, Mountain CF et al.: Cytodiagnosis of lung cancer. A report of a four-year laboratory, clinical, and statistical study, with a review of the literature on lung cancer and pulmonary cytology. Acta Cytol (Baltimore) 7:1–44, 1963.Google Scholar
  26. 25.
    Saccomanno G, Saunders RP, Ellis H et al.: Concentration of carcinoma or atypical cells in sputum. Acta Cytol 7:305–310, 1963.PubMedGoogle Scholar
  27. 26.
    Ikeda S, Yanai N, Ishikawa S: Flexible bronchofiberscope. Keio J Med 17:1–16, 1968.PubMedCrossRefGoogle Scholar
  28. 27.
    Fontana RS, Sanderson DR, Woolner LB et al.: The Mayo Lung Project for early detection and localization of bronchogenic carcinoma: A status report. Chest 67:511–522, 1975.PubMedCrossRefGoogle Scholar
  29. 28.
    Berlin NI, Buncher CR, Fontana RS et al.: The National Cancer Institute Cooperative Early Lung Cancer Detection Program: Results of the initial screen (prevalence): Introduction. Am Rev Respir Dis 130:545–549, 1984.PubMedGoogle Scholar
  30. 29.
    Frost JK, Ball WC Jr, Levin M et al.: Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 130:549–554, 1984.PubMedGoogle Scholar
  31. 30.
    Flehinger BJ, Melamed MR, Zaman MB et al.: Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 130:555–560, 1984.PubMedGoogle Scholar
  32. 31.
    The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Summary and conclusions. Am Rev Respir Dis 130:565–567, 1984.Google Scholar
  33. 32.
    Fontana RS, Taylor WF: Screening for lung cancer: The Mayo Lung Project. In: Lung cancer: Causes and prevention. Mizell M, Correa P (eds.). Deerfield Beach, Verlag Chemie International, pp 161–174, 1984.Google Scholar
  34. 33.
    Woolner LB, Fontana RS, Cortese DA et al.: Roentgenographically occult lung cancer: Pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc 59:453–466, 1984.PubMedGoogle Scholar
  35. 34.
    Cortese DA, Pairolero PC, Bergstralh EJ et al.: Roentgenographically occult lung cancer: A ten-year experience. J Thorac Cardiovasc Surg 86:373–380, 1983.PubMedGoogle Scholar
  36. 35.
    Eddy DM: Guidelines for the cancer-related checkup: Recommendations and rationale. CA-A J for Clinicians 30:193–240, 1980.Google Scholar
  37. 36.
    Enstrom JE, Austin DF: Interpreting cancer survival rates: The available data on survival are not a sensitive measure of progress in cancer control. Science 195:847–851, 1977.PubMedCrossRefGoogle Scholar
  38. 37.
    Zelen M, Feinleib M: On the theory of screening for chronic diseases. Biometrika 56:601–614, 1969.CrossRefGoogle Scholar
  39. 38.
    Hutchison GB, Shapiro S: Lead time gained by diagnostic screening for breast cancer. JNCI 41:665–673, 1968.PubMedGoogle Scholar
  40. 39.
    Morrison AS: The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening. Int J Epidemiol 11:261–267, 1982.PubMedCrossRefGoogle Scholar
  41. 40.
    Habbema JDF, Van Oortmarsen GJ, Van Pulten DJ: An analysis of survival differences between clinically and screen-detected cancer patients. Statistics in Medicine 2:279–285, 1983.PubMedCrossRefGoogle Scholar
  42. 41.
    Fontana RS, Sanderson DR, Woolner LB et al.: Lung cancer screening: The Mayo program. J Occup Med, in press.Google Scholar
  43. 42.
    Melamed MR, Flehinger BJ, Zaman MB et al.: Screening for lung cancer: Results of the Memorial Sloan-Kettering study in New York. Chest 86:44–53, 1984.PubMedCrossRefGoogle Scholar
  44. 43.
    Ball WC Jr, Frost JK, Tockman MS, Levin M: Screening for lung cancer: The effect of 5–7 years of periodic roentgenographic and cytologic examinations on detection, survival and mortality from lung cancer (Abstract). Am Rev Respir Dis 131:A84, 1985.Google Scholar
  45. 44.
    Paul O: The multiple risk factor intervention trial: A retrospective. J Cardiovasc Med 8:1071–1081, 1983.Google Scholar
  46. 45.
    Rossing TH, Rossing RG: Survival in lung cancer: An analysis of the effects of age, sex, resectability, and histopathologic type. Am Rev Respir Dis 126:771–777, 1982.PubMedGoogle Scholar
  47. 46.
    Muhm JR, Miller WE, Fontana RS et al.: Lung cancer detected during a screening program using four-month chest radiographs. Radiology 148:609–615, 1983.PubMedGoogle Scholar
  48. 47.
    Heelan RT, Flehinger BJ, Melamed MR et al.: Non-small cell cancer: Results of the New York screening program. Radiology 151:289–293, 1984.PubMedGoogle Scholar
  49. 48.
    McFarlane MJ, Feinstein AR, Wells CK: Factors in the surprise discovery of lung cancer at autopsy (Abstract). Clin Res 32:227A, 1984.Google Scholar
  50. 49.
    Nystrom JS, Weiner JM, Wolf RM et al.: Identifying the primary site in metastatic cancer of unknown origin: Inadequacy of roentgenographic procedures. JAMA 241:381–383, 1979.PubMedCrossRefGoogle Scholar
  51. 50.
    Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG: Treatment of the patient with adenocarcinoma of unknown origin. Cancer 30:1469–1472, 1972.PubMedCrossRefGoogle Scholar
  52. 51.
    Flehinger BJ, Melamed MR, Zaman MB et al.: Screening for early detection of lung cancer in New York. In: Screening for Cancer: General Principles on Evaluation of Screening for Cancer and Screening for Lung, Bladder, and Oral Cancer. Prorok PC, Millar AB (eds.). UICC Technical Report Series. Vol 78. Geneva, International Union Against Cancer, pp 123–135, 1984.Google Scholar
  53. 52.
    Melamed MR, Flehinger BJ: Screening for lung cancer (Editorial). Chest 86:2–3, 1984.PubMedCrossRefGoogle Scholar
  54. 53.
    Doll R: Symposium on presymptomatic diagnosis (discussion). Proc Roy Soc Med 59:1211–1213, 1966.Google Scholar
  55. 54.
    Shapiro S: Evidence on screening for breast cancer from a randomized trial. Cancer 39:2772–2782, 1977.PubMedCrossRefGoogle Scholar
  56. 55.
    Shapiro S, Venet W, Strax P, Venet L, Roeser R: Ten- to fourteen-year effect of screening on breast cancer mortality. JNCI 69:349–355, 1982.PubMedGoogle Scholar
  57. 56.
    Morrison AS: Case definition in case-control studies of the efficacy of screening. Am J Epidemiol 115:6–8, 1982.PubMedGoogle Scholar
  58. 57.
    Prorok PC, Chamberlain J, Day NE et al.: UICC workshop on the evaluation of screening programmes for cancer. Int J Cancer 34:1–4, 1984.PubMedCrossRefGoogle Scholar
  59. 58.
    Sackett DL, Holland WW: Controversy in the detection of disease. Lancet 2:357–359, 1975.PubMedCrossRefGoogle Scholar
  60. 59.
    Rucker L, Frye EB, Staten MA: Usefulness of screening roentgenograms in preoperative patients. JAMA 250:3209–3211, 1983.PubMedCrossRefGoogle Scholar
  61. 60.
    Detsky DS, Sackett DL: When was a ‘negative’ clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med 145:709–712, 1985.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1986

Authors and Affiliations

  • Robert S. Fontana

There are no affiliations available

Personalised recommendations